Efficacy and safety of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone for previously untreated diffuse large B-cell lymphoma: A real-world, multi-center, retrospective cohort study.

Authors: Peiqi Zhao, Shu Zhao, Chen Huang, Jiesong Wang, Junqing Xu, Yajun Li, Ningning Zhang, Hui Zhou, Yuhuan Gao, Qingyuan Zhang, Huilai Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.7061

Source: Full article

---

Abstract

7061